Search for: "ASTRAZENECA LP"
Results 101 - 120
of 154
Sorted by Relevance
|
Sort by Date
10 Oct 2017, 4:12 pm
Astrazeneca Pharmaceutical LP held a leave of absence or a leave extension can constitute a reasonable accommodation under the ADA “in some circumstances”, although in that case ultimately concluded the plaintiff could not show her request for twelve additional months of leave was facially reasonable. [read post]
30 Jun 2010, 5:52 am
(Docket Report) US: Update on reverse settlement agreements – Amici curiae brief filed with US Court of Appeals: In re Ciprofloxacin Hydrochloride Antitrust Litigation (IP Whiteboard) (PatLit) US: An uneven debate on ‘takings’ in pharmaceutical patent law (Patent Docs) Products Aldara (Imiquimod) – US: Graceway’s injunction and Nycomed’s dismissal denied in Aldara suit (Patent Docs) Argatroban – US: Patent for Argatroban found valid, injunction issued… [read post]
10 Oct 2017, 4:12 pm
Astrazeneca Pharmaceutical LP held a leave of absence or a leave extension can constitute a reasonable accommodation under the ADA “in some circumstances”, although in that case ultimately concluded the plaintiff could not show her request for twelve additional months of leave was facially reasonable. [read post]
16 Apr 2012, 1:29 am
District Court are Motions for Summary Judgment filed by FDA and AstraZeneca Pharmaceuticals LP (here and here) concerning FDA’s approval of ANDAs for generic versions of SEROQUEL (quetiapine fumarate) Tablets and the Agency’s decision, discussed in a March 27, 2012 Letter Decision, concerning the scope and applicability of 3-year marketing exclusivity in that case. [read post]
16 Jul 2010, 12:10 pm
LP v. [read post]
12 Jan 2010, 7:26 am
"); AstraZeneca LP v. [read post]
29 Jun 2010, 6:01 pm
(Docket Report) US: Update on reverse settlement agreements – Amici curiae brief filed with US Court of Appeals: In re Ciprofloxacin Hydrochloride Antitrust Litigation (IP Whiteboard) (PatLit) US: An uneven debate on ‘takings’ in pharmaceutical patent law (Patent Docs) Products Aldara (Imiquimod) – US: Graceway’s injunction and Nycomed’s dismissal denied in Aldara suit (Patent Docs) Argatroban – US: Patent for Argatroban found valid, injunction… [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs) Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
23 Jul 2009, 3:15 am
Astrazeneca Pharmaceuticals LP), because of Bexis' firm's involvement in the litigation (although not this aspect). [read post]
6 May 2017, 10:11 am
The decision Braintree v. [read post]
18 Dec 2015, 9:19 am
AstraZeneca Pharm. [read post]
26 Jan 2011, 1:31 am
In April of last year, we obtained a $520 million settlement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to resolve allegations that marketing of the anti-psychotic drug Seroquel for uses not approved as safe and effective by the FDA caused false claims to be submitted to federal health care programs. [read post]
25 Oct 2013, 3:56 am
In the court’s view, this circumstantial evidence of a “pattern of antagonism” raised an inference of retaliation and was enough to support her Title VII claim (Brangman v AstraZeneca, LP). [read post]
18 Oct 2011, 9:33 am
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352 (11th Cir. 2011)? [read post]
8 Jan 2009, 4:07 am
Astrazeneca Pharmaceuticals LP, 2008 WL 4832659 (M.D. [read post]
17 Dec 2015, 11:54 am
Patents in his portfolio include US Patent Numbers 6,331,400, 6,771,291, 7,353,199, 7,996,259, 8,335,713, 8,412,570, 8,417,567, 8,423,399, 8,442,860, 8,589,222, 8,650,076, 8,768,760, 8,781,890 and 8,996,398.[8] = = = = = [1] US patent Application No. 10/868,312, claim number 24. [2] See 1 Chisum on Patents section 1.02. [3] In re Russell, 48 F.2d 668, 669 (CCPA 1931)(indexing the names in directories and dictionaries). [4] AstraZeneca LP v. [read post]
4 May 2017, 6:55 am
Astrazeneca Pharmaceutical, LP, May 2, 2017, Thompson, O.). [read post]
18 Mar 2024, 9:46 am
AstraZeneca Pharmaceuticals, LP 23-665Issue: Whether, where an unemployment applicant’s religious beliefs are independently sufficient to cause her refusal to follow an employer policy, a state can deny her unemployment benefits by holding that philosophical and personal beliefs outweigh her religious beliefs. [read post]
12 May 2010, 11:34 am
AstraZeneca Pharms. [read post]
13 May 2020, 2:03 am
Astrazeneca Pharms., LP, 500 F. [read post]
